Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-052727
Filing Date
2015-06-12
Accepted
2015-06-12 16:02:40
Documents
1
Period of Report
2015-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4389
  Complete submission text file 0001209191-15-052727.txt   5803
Mailing Address C/O SATTER INVESTMENT MANAGEMENT, LLC 676 NORTH MICHIGAN AVENUE, SUITE 4000 CHICAGO IL 60611
Business Address
Satter Muneer A (Reporting) CIK: 0001315797 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36352 | Film No.: 15928483

Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations